OMRON Healthcare Announces Second Investment in Tricog Health to Advance AI-Powered Cardiac Care in India
KYOTO, Japan, Nov. 12, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd. today…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…
IMG Expands iTravelInsured Choice with New Add-Ons and Specialized Plans
INDIANAPOLIS, Oct. 14, 2025 /PRNewswire/ -- IMG (International Medical Group) has announced…
Market Alert: AlphaTON Capital Continues in Growth Mode and Purchases an additional 300,000 TON
Dover, DE, Oct. 12, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq:…
Automobili Lamborghini strengthens its Board of Management
New appointments to support the future strategy of the Sant’Agata Bolognese companySant’Agata…
Kia PV5 Redefines Mobility ThroughCustomerCentric Modular Design
Built to meet customers’ evolving needs, PV5 is first dedicated model in…
Massive Gaming Launches Tablet-Based Slot Titles for On-Premises Environment
Five MVG titles debut, with additional games to follow in phased rollout…
Kia advances EV Mobility experience with new Plug and Charge Technology
Kia Plug & Charge technology for seamless EV charging at compatible stations…
Factor2 Energy Raises US$9.1M to Unlock Scalable Geothermal Power from Geologically Stored CO
DUISBURG, Germany, Sept. 19, 2025 /PRNewswire/ --Â Factor2 Energy, a German (Duisburg) company…
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…